Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04242446
Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (BE HEARD I)

First Submitted : January 23, 2020
First Submitted that Met QC Criteria : January 23, 2020
First Posted : January 27, 2020

Last Update Submitted that Met QC Criteria : August 2, 2022
Last Update Posted : August 3, 2022